János Sápi

2.0k total citations
92 papers, 1.7k citations indexed

About

János Sápi is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, János Sápi has authored 92 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Organic Chemistry, 39 papers in Molecular Biology and 8 papers in Pharmacology. Recurrent topics in János Sápi's work include Asymmetric Synthesis and Catalysis (16 papers), Chemical synthesis and alkaloids (14 papers) and Synthesis and Biological Evaluation (11 papers). János Sápi is often cited by papers focused on Asymmetric Synthesis and Catalysis (16 papers), Chemical synthesis and alkaloids (14 papers) and Synthesis and Biological Evaluation (11 papers). János Sápi collaborates with scholars based in France, Hungary and Italy. János Sápi's co-authors include Jean‐Yves Laronze, Stéphane Gérard, Antonella Fontana, Andrea Renzetti, Andrei N. Khlobystov, Graham A. Rance, Marc Pudlo, Gautier Moroy, William Hornebeck and Michel Boisbrun and has published in prestigious journals such as Chemistry of Materials, Chemical Communications and Journal of Materials Chemistry A.

In The Last Decade

János Sápi

91 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
János Sápi France 25 1.2k 614 146 137 128 92 1.7k
Bang‐Chi Chen United States 25 1.7k 1.5× 661 1.1× 106 0.7× 65 0.5× 67 0.5× 76 2.2k
Thomas J. Blacklock United States 32 2.1k 1.8× 801 1.3× 176 1.2× 196 1.4× 62 0.5× 105 2.7k
Benoı̂t Rigo France 22 1.5k 1.3× 638 1.0× 119 0.8× 62 0.5× 36 0.3× 149 1.8k
David M. Tschaen United States 27 2.0k 1.7× 792 1.3× 132 0.9× 143 1.0× 72 0.6× 63 2.5k
Edward R. Biehl United States 24 1.3k 1.1× 690 1.1× 89 0.6× 104 0.8× 53 0.4× 153 1.9k
Chi‐Sing Lee China 27 942 0.8× 471 0.8× 222 1.5× 219 1.6× 70 0.5× 77 1.7k
Takeo Konakahara Japan 30 2.4k 2.0× 853 1.4× 129 0.9× 204 1.5× 31 0.2× 158 2.9k
Emily A. Peterson United States 15 1.3k 1.1× 326 0.5× 113 0.8× 52 0.4× 139 1.1× 34 1.7k
Carl J. Lovely United States 30 2.3k 2.0× 413 0.7× 108 0.7× 81 0.6× 72 0.6× 100 2.7k
Lásʐló Tőke Hungary 28 2.9k 2.4× 648 1.1× 587 4.0× 250 1.8× 89 0.7× 246 3.4k

Countries citing papers authored by János Sápi

Since Specialization
Citations

This map shows the geographic impact of János Sápi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by János Sápi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites János Sápi more than expected).

Fields of papers citing papers by János Sápi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by János Sápi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by János Sápi. The network helps show where János Sápi may publish in the future.

Co-authorship network of co-authors of János Sápi

This figure shows the co-authorship network connecting the top 25 collaborators of János Sápi. A scholar is included among the top collaborators of János Sápi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with János Sápi. János Sápi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Braux, Julien, Renaud Siboni, Christine Guillaume, et al.. (2022). Inhibition of Recruitment and Activation of Neutrophils by Pyridazinone-Scaffold-Based Compounds. International Journal of Molecular Sciences. 23(13). 7226–7226. 8 indexed citations
2.
Braux, Julien, Christine Guillaume, Sandra Audonnet, et al.. (2021). Pyridazinone Derivatives Limit Osteosarcoma-Cells Growth In Vitro and In Vivo. Cancers. 13(23). 5992–5992. 4 indexed citations
3.
Samokhvalov, Pavel, et al.. (2021). Conjugates of Ultrasmall Quantum Dots and Acridine Derivatives as Prospective Nanoprobes for Intracellular Investigations. Nanomaterials. 11(9). 2160–2160. 1 indexed citations
4.
Samokhvalov, Pavel, et al.. (2020). Selection of the Optimal Chromatography Medium for Purification of Quantum Dots and Their Bioconjugates. Chemistry of Materials. 32(21). 9078–9089. 6 indexed citations
5.
Ceruso, Mariangela, et al.. (2019). 5-Arylisothiazol-3(2H)-one-1,(1)-(di)oxides: A new class of selective tumor-associated carbonic anhydrases (hCA IX and XII) inhibitors. European Journal of Medicinal Chemistry. 175. 40–48. 13 indexed citations
6.
Samokhvalov, Pavel, et al.. (2018). The Effect of Quantum Dot Shell Structure on Fluorescence Quenching By Acridine Ligand. KnE Energy. 3(2). 194–194. 2 indexed citations
7.
Szymoniak, Jan, Frédéric Fabis, Sylvain Rault, et al.. (2012). Cyclopropyl‐tryptamine Analogues: Synthesis and Biological Evaluation as 5‐HT6 Receptor Ligands. ChemMedChem. 8(1). 70–73. 1 indexed citations
8.
Moroy, Gautier, et al.. (2012). Neutrophil Elastase as a Target in Lung Cancer. Anti-Cancer Agents in Medicinal Chemistry. 12(6). 565–579. 62 indexed citations
9.
Pudlo, Marc, et al.. (2012). First domino radical cyclisation/Smiles rearrangement combination. Chemical Communications. 48(18). 2442–2442. 43 indexed citations
10.
Lansiaux, Amélie, Jean‐Marc Nuzillard, Olivier Lozach, et al.. (2010). Synthesis and biological evaluation of new penta- and heptacyclic indolo- and quinolinocarbazole ring systems obtained via Pd0 catalysed reductive N-heteroannulation. Organic & Biomolecular Chemistry. 8(20). 4625–4625. 14 indexed citations
11.
Sápi, János, et al.. (2009). Control of Melanoma Invasiveness by Anticollagenolytic Agents: A Reappraisal of an Old Concept. Anti-Cancer Agents in Medicinal Chemistry. 9(5). 576–597. 10 indexed citations
12.
Moroy, Gautier, Dominique Guillaume, Franck Augé, et al.. (2008). Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity. Bioorganic & Medicinal Chemistry. 16(18). 8745–8759. 36 indexed citations
13.
Moroy, Gautier, Clément Denhez, Haquima El Mourabit, et al.. (2007). Simultaneous presence of unsaturation and long alkyl chain at P1′ of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies. Bioorganic & Medicinal Chemistry. 15(14). 4753–4766. 20 indexed citations
14.
Pudlo, Marc, Stéphane Gérard, Catherine Mirand, & János Sápi. (2007). A tandem radical cyclization approach to 3-(2-oxopyrrolidin-3-yl)indolin-2-ones, potential intermediates toward complex indole-heterocycles. Tetrahedron Letters. 49(6). 1066–1070. 9 indexed citations
15.
Toribio, Alix, et al.. (2006). Multiple dual-mode centrifugal partition chromatography, a semi-continuous development mode for routine laboratory-scale purifications. Journal of Chromatography A. 1127(1-2). 45–51. 81 indexed citations
16.
Boisbrun, Michel, et al.. (2003). Multicomponent approach for the synthesis of non-natural tryptophan, tryptamine and β-carboline derivatives. Comptes Rendus Chimie. 6(5-6). 517–528. 17 indexed citations
17.
18.
19.
Hajós, György, et al.. (2000). Synthesis of two new heteroaromatic β-carboline-fused pentacycles. observation of a new intercalating agent. Bioorganic & Medicinal Chemistry Letters. 10(15). 1767–1769. 38 indexed citations
20.
Laronze, Jean‐Yves, Denis Séraphin, Eric A. Noe, et al.. (1995). Synthesis of Compounds with the Novel 2,3,7-Triazaphenalene Ring System. Heterocycles. 41(1). 29–29. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bang‐Chi Chen Breakdown of academic impact, for papers by Thomas J. Blacklock Breakdown of academic impact, for papers by Benoı̂t Rigo Breakdown of academic impact, for papers by David M. Tschaen Breakdown of academic impact, for papers by Edward R. Biehl Breakdown of academic impact, for papers by Chi‐Sing Lee Breakdown of academic impact, for papers by Takeo Konakahara Breakdown of academic impact, for papers by Emily A. Peterson Breakdown of academic impact, for papers by Carl J. Lovely Breakdown of academic impact, for papers by Lásʐló Tőke
Rankless by CCL
2026